You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Celldex

Showing 26 - 50 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Subjects Trial in Overland Park (CDX-0159, Normal saline)

Completed
  • Healthy Subjects
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc.
Jul 2, 2020

Renal Cell Carcinoma (RCC), Clear-cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in United States (CDX-014)

Terminated
  • Renal Cell Carcinoma (RCC)
  • +5 more
  • Scottsdale, Arizona
  • +4 more
Jun 2, 2020

Malignant Glioma Trial in United States (CDX-110 with GM-CSF, Temozolomide)

Completed
  • Malignant Glioma
  • Orange, California
  • +33 more
Jan 11, 2018

Prostatic Tumors, Prostate Cancer Trial in Charlottesville (CDX1127, SBRT)

Terminated
  • Prostatic Neoplasms
  • Prostate Cancer
  • CDX1127
  • SBRT
  • Charlottesville, Virginia
    University of Virginia
May 16, 2018

Triple Negative Breast Cancer Trial (Glembatumumab Vedotin)

Withdrawn
  • Triple Negative Breast Cancer
  • Glembatumumab Vedotin
  • (no location specified)
May 30, 2018

Bladder Cancer Trial in United States (CDX-1307 Vaccine Regimen, Chemotherapy)

Terminated
  • Bladder Cancer
  • Phoenix, Arizona
  • +16 more
Feb 10, 2020

Advanced Breast Carcinoma, Advanced Ovarian Carcinoma Trial in United States (ONT-10, Varlilumab combination)

Completed
  • Advanced Breast Carcinoma
  • Advanced Ovarian Carcinoma
  • ONT-10, Varlilumab combination
  • Birmingham, Alabama
  • +3 more
May 14, 2018

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Ovarian Carcinoma-Enrollment Completed, Colorectal Cancer (CRC)-Enrollment

Completed
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • +4 more
  • Combination of varlilumab and nivolumab
  • Tucson, Arizona
  • +18 more
Dec 5, 2019

Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in United States (Bevacizumab, Rindopepimut (CDX-110) with

Completed
  • Glioblastoma
  • +6 more
  • Birmingham, Alabama
  • +44 more
Feb 12, 2020

Squamous Cell Carcinoma of the Head and Neck Trial in San Francisco, Pittsburgh (KTN3379)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • KTN3379
  • San Francisco, California
  • +1 more
Jul 30, 2019

Advanced Cancer Trial in Boston, Portland, Nashville (CDX-0158 (formerly known as KTN-0158))

Completed
  • Advanced Cancer
  • CDX-0158 (formerly known as KTN-0158)
  • Boston, Massachusetts
  • +3 more
Jun 11, 2019

Melanoma Trial in United States (glembatumumab vedotin, glembatumumab vedotin and varlilumab, glembatumumab vedotin and PD-1

Terminated
Has Results
  • Melanoma
  • glembatumumab vedotin
  • +3 more
  • Los Angeles, California
  • +13 more
Sep 5, 2019

Metastatic gpNMB Expressing Triple Negative Breast Cancer Trial (glembatumumab vedotin)

No longer available
  • Metastatic gpNMB Expressing Triple Negative Breast Cancer
  • glembatumumab vedotin
  • (no location specified)
May 17, 2018

Obesity Trial in Nottingham (Cellodextrin)

Completed
  • Obesity
  • Cellodextrin
  • Nottingham, Notts, United Kingdom
    David Greenfield Human Physiology Unit
Jun 3, 2019

Metastatic gpNMB Over-expressing Triple Negative Breast Cancer Trial in Worldwide (CDX-011, Capecitabine)

Completed
Has Results
  • Metastatic gpNMB Over-expressing Triple Negative Breast Cancer
  • Birmingham, Alabama
  • +139 more
Mar 6, 2019

Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of varlilumab and sunitinib)

Terminated
  • Carcinoma, Renal Cell
  • +8 more
  • Combination of varlilumab and sunitinib
  • Birmingham, Alabama
  • +8 more
Jul 24, 2018

Recurrent GBM Trial (rindopepimut)

No longer available
  • Recurrent GBM
  • rindopepimut
  • (no location specified)
Oct 16, 2017

Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of Varlilumab and Atezolizumab)

Terminated
  • Carcinoma, Renal Cell
  • +13 more
  • Combination of Varlilumab and Atezolizumab
  • San Francisco, California
  • +3 more
Apr 26, 2018

CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in

Completed
  • CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma
  • +9 more
  • Scottsdale, Arizona
  • +9 more
Jan 29, 2018

Thyroid Cancer Trial in New York (KTN3379, vemurafenib)

Completed
  • Thyroid Cancer
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Aug 31, 2017

Advanced Cancer Trial in United States (KTN3379)

Completed
  • Advanced Cancer
  • KTN3379
  • Denver, Colorado
  • +4 more
Jul 21, 2017

Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in Worldwide (Rindopepimut (CDX-110) with GM-CSF,

Completed
  • Glioblastoma
  • +4 more
  • Rindopepimut (CDX-110) with GM-CSF
  • +2 more
  • Birmingham, Alabama
  • +222 more
Jan 11, 2018

Healthy Trial in New York (CDX-301)

Completed
  • Healthy
  • New York, New York
    Rockefeller University
Jun 26, 2017

Breast Cancer Trial in United States (CDX-011, "Investigator's Choice" chemo)

Completed
  • Breast Cancer
  • CDX-011
  • "Investigator's Choice" chemotherapy
  • Birmingham, Alabama
  • +23 more
Jun 26, 2017

Unresectable Stage III or Stage IV Melanoma Trial in United States (Combination of varlilumab and ipilimumab, Cohort A:

Terminated
  • Unresectable Stage III or Stage IV Melanoma
  • Combination of varlilumab and ipilimumab
  • Cohort A: varlilumab & ipilimumab; Cohort B: varlilumab, ipilimumab, CDX-1401 & poly-ICLC
  • San Francisco, California
  • +7 more
Apr 6, 2017